Protective  	Protective  	 JJ	B-NP
activity  	activity  	 NN	I-NP
of  	of  	 IN	I-NP
guanosine  	guanosine  	 NN	I-NP
in  	in  	 IN	O
an  	an  	 DT	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
model  	model  	 NN	I-NP
of  	of  	 IN	O
Parkinson 	Parkinson 	 NNP	O
's  	's  	 POS	O
disease  	disease  	 NN	B-NP
Parkinson 	Parkinson 	 NNP	I-NP
's  	's  	 POS	O
disease  	disease  	 NN	O
( 	( 	 -LRB-	O
PD 	PD 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
pathological  	pathological  	 JJ	B-NP
condition  	condition  	 NN	I-NP
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
progressive  	progressive  	 JJ	B-NP
neurodegeneration  	neurodegeneration  	 NN	I-NP
of  	of  	 IN	I-NP
dopaminergic  	dopaminergic  	 JJ	I-NP
neurons  	neurons  	 NN	I-NP
with  	with  	 IN	O
the  	the  	 DT	O
consequent  	consequent  	 JJ	O
reduction  	reduction  	 NN	O
of  	of  	 IN	O
dopamine  	dopamine  	 JJ	B-NP
content  	content  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
substantia  	substantia  	 JJ	B-NP
nigra 	nigra 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
neurotoxin  	neurotoxin  	 JJ	O
6-hydroxydopamine  	6-hydroxydopamine  	 NNP	O
( 	( 	 -LRB-	O
6-OHDA 	6-OHDA 	 NNP	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
widely  	widely  	 RB	O
used  	used  	 VBN	O
to  	to  	 TO	O
mimic  	mimic  	 VB	O
the  	the  	 DT	O
neuropathology  	neuropathology  	 NN	B-NP
of  	of  	 IN	I-NP
PD  	PD  	 NNP	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
in  	in  	 IN	O
vivo  	vivo  	 NN	B-NP
and  	and  	 CC	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
experimental  	experimental  	 JJ	I-NP
models 	models 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
found  	found  	 VBD	O
that 	that 	 IN	O
,  	,  	 ,	O
as  	as  	 RB	O
expected 	expected 	 VBN	O
,  	,  	 ,	O
in  	in  	 IN	O
dopaminergic  	dopaminergic  	 JJ	O
human  	human  	 JJ	O
SH-SY5Y  	SH-SY5Y  	 CD	O
neuroblastoma  	neuroblastoma  	 CD	O
cells  	cells  	 NNS	O
the  	the  	 DT	O
toxin  	toxin  	 NN	B-NP
reduced  	reduced  	 VBN	O
cell  	cell  	 NN	O
viability  	viability  	 NN	O
causing  	causing  	 VBG	O
programmed  	programmed  	 JJ	O
cell  	cell  	 NN	O
death  	death  	 NN	O
as  	as  	 IN	O
assessed  	assessed  	 VBN	O
by  	by  	 IN	O
an  	an  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
DNA  	DNA  	 NNP	B-NP
fragmentation 	fragmentation 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
also  	also  	 RB	O
examined 	examined 	 VBN	O
,  	,  	 ,	O
in  	in  	 IN	O
these  	these  	 DT	O
cells 	cells 	 NNS	O
,  	,  	 ,	O
the  	the  	 DT	O
activation 	activation 	 JJ	O
/ 	/ 	 CD	O
inactivation  	inactivation  	 NN	O
of  	of  	 IN	O
several  	several  	 JJ	O
pro  	pro  	 NN	O
and  	and  	 CC	O
anti  	anti  	 FW	B-NP
apoptotic  	apoptotic  	 FW	I-NP
signaling  	signaling  	 FW	I-NP
pathways  	pathways  	 FW	I-NP
by  	by  	 FW	O
6-OHDA  	6-OHDA  	 FW	O
including  	including  	 FW	B-NP
p-38  	p-38  	 FW	I-NP
kinase  	kinase  	 FW	I-NP
( 	( 	 -LRB-	O
p-38 	p-38 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
c-Jun  	c-Jun  	 JJ	B-NP
N-terminal  	N-terminal  	 JJ	I-NP
kinase  	kinase  	 NNS	I-NP
( 	( 	 -LRB-	O
JNK 	JNK 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
protein  	protein  	 NN	B-NP
kinase  	kinase  	 VBD	O
B  	B  	 NNP	O
( 	( 	 -LRB-	O
also  	also  	 RB	O
known  	known  	 VBN	O
as  	as  	 IN	O
Akt 	Akt 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
glycogen  	glycogen  	 FW	B-NP
synthase  	synthase  	 FW	I-NP
kinase-3β  	kinase-3β  	 FW	I-NP
( 	( 	 -LRB-	O
GSK3β 	GSK3β 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
Bcl-2  	Bcl-2  	 CD	B-NP
protein 	protein 	 NN	I-NP
.  	.  	 .	O
Guanine-based  	Guanine-based  	 JJ	B-NP
purines 	purines 	 NN	I-NP
,  	,  	 ,	O
exert  	exert  	 JJ	O
neuroprotective  	neuroprotective  	 JJ	B-NP
effects  	effects  	 NNS	I-NP
and  	and  	 CC	O
we  	we  	 PRP	O
previously  	previously  	 RB	O
reported  	reported  	 VBN	O
that  	that  	 IN	O
guanosine  	guanosine  	 FW	B-NP
activates  	activates  	 FW	O
cell  	cell  	 FW	O
survival  	survival  	 FW	O
pathways  	pathways  	 FW	O
including  	including  	 FW	O
PI3K 	PI3K 	 FW	O
/ 	/ 	 FW	O
Akt 	Akt 	 FW	B-NP
/ 	/ 	 FW	I-NP
PKB  	PKB  	 FW	I-NP
signaling  	signaling  	 FW	O
in  	in  	 IN	O
different  	different  	 JJ	O
kinds  	kinds  	 NNS	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
including  	including  	 VBG	B-NP
glia  	glia  	 NNS	I-NP
and  	and  	 CC	O
neuroblastoma  	neuroblastoma  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
present  	present  	 JJ	O
study  	study  	 NN	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 DT	O
guanosine  	guanosine  	 NN	B-NP
( 	( 	 -LRB-	O
300  	300  	 CD	O
µM 	µM 	 NN	B-NP
)  	)  	 -RRB-	O
protected  	protected  	 VBD	O
SH-SY5Y  	SH-SY5Y  	 CD	O
neuroblastoma  	neuroblastoma  	 CD	O
cells  	cells  	 NNS	O
when  	when  	 WRB	O
they  	they  	 PRP	O
were  	were  	 VBD	O
exposed  	exposed  	 VBN	O
to  	to  	 TO	O
6-OHDA 	6-OHDA 	 CD	O
,  	,  	 ,	O
promoting  	promoting  	 VBG	O
their  	their  	 PRP$	O
survival 	survival 	 NN	O
.  	.  	 .	O
Guanosine  	Guanosine  	 NNP	B-NP
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
6-OHDA  	6-OHDA  	 JJ	O
mediated  	mediated  	 JJ	O
activation  	activation  	 NN	B-NP
of  	of  	 IN	I-NP
p-38  	p-38  	 NNP	I-NP
and  	and  	 CC	O
JNK 	JNK 	 NNP	B-NP
.  	.  	 .	O
Moreover  	Moreover  	 RB	O
the  	the  	 DT	O
nucleoside  	nucleoside  	 NN	B-NP
potentiated  	potentiated  	 VBD	O
the  	the  	 DT	O
early  	early  	 JJ	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
phosphorylation  	phosphorylation  	 NN	B-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
anti-apoptotic  	anti-apoptotic  	 JJ	I-NP
kinase  	kinase  	 JJ	I-NP
Akt  	Akt  	 NNP	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
increase  	increase  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
expression  	expression  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
anti-apoptotic  	anti-apoptotic  	 JJ	B-NP
Bcl-2  	Bcl-2  	 CD	I-NP
protein  	protein  	 NN	I-NP
induced  	induced  	 NN	I-NP
by  	by  	 IN	O
6-OHDA 	6-OHDA 	 CD	O
.  	.  	 .	O
In  	In  	 IN	O
summary  	summary  	 VBG	O
our  	our  	 PRP$	O
results  	results  	 NNS	O
show  	show  	 VBP	O
that  	that  	 IN	O
guanosine  	guanosine  	 JJ	B-NP
results  	results  	 NNS	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
neuroprotective  	neuroprotective  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
recognized  	recognized  	 VBN	O
in  	in  	 IN	O
vitro  	vitro  	 JJ	B-NP
model  	model  	 NN	I-NP
of  	of  	 IN	I-NP
PD  	PD  	 NNP	I-NP
thus  	thus  	 RB	O
suggesting  	suggesting  	 VBG	O
that  	that  	 IN	O
it  	it  	 PRP	O
could  	could  	 MD	O
represent  	represent  	 VB	O
a  	a  	 DT	O
new  	new  	 JJ	O
potential  	potential  	 JJ	B-NP
pharmacological  	pharmacological  	 JJ	I-NP
tool  	tool  	 NN	I-NP
to  	to  	 TO	O
be  	be  	 VB	O
studied  	studied  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
therapeutic  	therapeutic  	 JJ	B-NP
approach  	approach  	 NN	I-NP
to  	to  	 TO	O
PD 	PD 	 NNP	B-NP
.  	.  	 .	O
